Contact Us: 1-888-667-3325 / customerservice@thedeal.com

Subscriber Content Preview | Request a free trialSearch  
  Go

Entries tagged "Gary Loveman"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Gary Loveman."

5 result(s) displayed (1 - 5 of 5)


Caesars begins Chapter 11 play

The operating unit of the casino giant looks to shed roughly $10 billion in debt through the court restructuring. Continue reading

Posted on January 15, 2015 12:51 PM




Caesars to enter into formal talks with bank lenders

Some observers believe the troubled casino operator will try to convince these powerful creditors to become involved in some large decisions, while others feel a prenegotiated bankruptcy filing is the likeliest outcome. Continue reading

Posted on October 21, 2014 9:19 AM




Caesars Entertainment plummets toward Ch. 11

One hedge fund says the company would need 'a meteor to destroy the earth' to avoid bankruptcy. Continue reading

Posted on July 31, 2013 12:59 PM




Caesars' IPO: The exception that proves the rule

PE-backed initial public offerings do best when there's little leverage, or their proceeds are being used to pay down debt. Then there's the casino and hotel operator formerly known as Harrah's Entertainment. Continue reading

Posted on May 4, 2012 1:33 PM




TDE 2012: Loveman of Caesars Entertainment

Gary Loveman, Chairman, CEO and President of Caesars Entertainment, sat down with CNBC host Scott Wapner at The Deal Economy 2012 at the New York Stock Exchange Continue reading

Posted on December 1, 2011 6:18 PM






Movable Type search results powered by Fast Search



Popular tags




Movers & Shakers

Launch Movers and shakers slideshow

American International Group picks up a new CIO, Douglas A. Dachille, with the acquisition of First Principles Capital Management. For other updates launch today's Movers & shakers slideshow.

Video

Teva springs for $40.5B Allergan Generics acquisition

Teva Pharmaceutical will acquire the generics business of Botox maker Allergan and subsequently abandon a $40 billion, hostile pursuit for its peer Mylan. More video

Sectors